The effect of bromocriptine on endometrioma size

Phase 2

• Conditions: Endometrioma.; Endometriosis of ovary; N80.1

• Registration Number: IRCT20140802018655N6
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

A definitive diagnosis of endometrioma

Exclusion Criteria

patients with hyperprolactinemia
People with coagulation disorders
who have contraindications to medroxyprogesterone

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Endometrioma size. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: Ultrasonography.;Pain pelvic. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test.

Secondary Outcome Measures

Name	Time	Method
Dysmenorrhea. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test.;Dyspareunia. Timepoint: Before transplantation and at the end of 3 months. Method of measurement: VAS test.